Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study
- PMID: 15887725
Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study
Abstract
Purpose: To evaluate the efficacy of topical (1%) and systemic itraconazole against common fungi such as Aspergillus and other filamentous fungi that cause mycotic corneal ulcer.
Methods: A prospective randomised, controlled study was done in 54 clinically suspected cases of fungal keratitis of which 44 were culture proven. Half the cases (n=27) with superficial involvement were treated with only topical itraconazole (1%) and the other half were treated with both topical and systemic itraconazole.
Results: Aspergillus, Penicillium and Fusarium were the most common fungi isolated. The ulcer resolved in 42 eyes (77%) and 12 eyes (23%) did not respond well to treatment. Four of 12 non-responding eyes were caused by Fusarium species.
Conclusion: Itraconazole, given either topically or systemically, is effective in treating mycotic corneal ulcers.
Comment in
-
Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study.Indian J Ophthalmol. 2002 Mar;50(1):70-1; author reply 72. Indian J Ophthalmol. 2002. PMID: 12090096 No abstract available.
-
Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study.Indian J Ophthalmol. 2002 Mar;50(1):70; author reply 72. Indian J Ophthalmol. 2002. PMID: 12090097 No abstract available.
-
Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study.Indian J Ophthalmol. 2002 Mar;50(1):71-2; author reply 72. Indian J Ophthalmol. 2002. PMID: 12090098 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
